Page 807 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 763

Cyclooxygenase inhibition Cytoplasmic membrane (bacterial), Decussation De novo synthesis
irreversible, 486 124 in spinal tracts, 509 pyrimidine and purine, 36, 73
reversible, 485, 486 Cytoplasmic processing bodies Deep brachial artery, 455 Dense deposit disease, 596
selective, 486 (P-bodies), 41 Deep inguinal lymph nodes, 624 Dental plaque
Cyclophosphamide, 441 Cytoskeletal elements, 48 Deep venous thrombosis (DVT), 671 normal flora, 178
hemorrhagic cystitis with, 249 Cytotoxic T cells, 102 direct factor Xa inhibitors for, 437 viridans streptococci, 128
microscopic polyangiitis, 315 cell surface proteins, 110 glucagonomas and, 351 Dentate line, 366
SIADH with, 249 MHC I and II, 100 heparin for, 436 Dentate nucleus, 499
toxicities of, 444 Cytotrophoblast, 617 tamoxifen/raloxifene and, 443 Dentin
transitional cell carcinoma and, Deer flies (disease vectors), 159 collagen in, 50
606 D Defense mechanisms osteogenesis imperfecta, 51
Wegener granulomatosis, 315 Dabigatran, 435 immature, 554–555 Dentinogenesis imperfecta, 51
Cycloplegia Dabrafenib, 444 mature, 555 Denys-Drash syndrome, 606
atropine, 241 Daclizumab Defensins, 99 Dependent personality disorder, 566
muscarinic antagonists for, 241 targets of, 121 Deferasirox, 248 Depersonalization/derealization
Cyclosporine Dacrocytes, 414 Deferiprone, 248 disorder, 558
gingival hyperplasia, 250 Dactinomycin, 439 Deferoxamine, 248 panic disorder, 563
gout, 250 RNA polymerase inhibition, 42 Deformation, 613 Depolarizing neuromuscular
immunosuppression, 120 targets of, 438 Degarelix, 656 blocking drugs, 551
Cyclothymic disorder, 561 Dactylitis Degenerate/redundant genetic code, 37 Depressants, intoxication and
Cystathionine, 67 seronegative spondyloarthritis, 469 Degmacytes, 414 withdrawal, 570
Cystathionine synthase deficiency, 84 sickle cell anemia, 422 G6PD deficiency, 79 Depression
Cyst disorders (renal), 604 Dalfopristin Dehydration atypical features in, 561
Cysteine, 85 VRE, 198 diabetic ketoacidosis, 347 benzodiazepine withdrawal, 570
Cystic duct, 368 Danazol, 658 filtration changes and, 583 dissociative identity disorder, 558
Cystic fibrosis, 60 pseudotumor cerebri, 521 gout exacerbation, 467 drug therapy, 572
Aspergillus fumigatus, 153 “Dancing eyes, dancing feet,” 228 loop diuretics and, 608 electroconvulsive therapy, 562
bronchiectasis, 675 Dandy-Walker syndrome, 492 mannitol and, 607 hyperparathyroidism, 345
chromosome association, 64 Dantrolene, 550, 551 osmotic laxatives, 401 metoclopramide, 400
common organisms, 179 Dapagliflozin, 353 salivary stones with, 376 mirtazapine for, 244
meconium ileus and, 386 Dapsone shock, 310 neurotransmitters for, 495
N-acetylcysteine, 686 Hansen disease, 141 Dehydrogenases, 73 postpartum, 562
pancreatic insufficiency, 381 hemolysis in G6PD deficiency, 250 Delavirdine seasonal pattern with, 561
vitamin deficiencies and, 65 mechanism and use, 194 HIV therapy, 203 serotonin-norepinephrine reuptake
Cystine, 598 Mycobacterium leprae, 196 Delirium, 558 inhibitors (SNRIs) for, 575
Cystinuria, 85 Pneumocystis jirovecii, 154 barbiturate withdrawal, 570 SSRIs for, 575
Cystitis Daptomycin diabetic ketoacidosis, 347 Deprivation effects (infants), 556
acute bacterial, 594, 600 mechanism and use, 195 PCP, 571 De Quervain tenosynovitis, 461
squamous cell carcinoma risk, 606 MRSA, 198 thyroid storm, 342 De Quervain thyroiditis, 341
Cytarabine, 440 Darkfield microscopy Delirium tremens (DTs), 569, 570 Dermacentor tick (disease vector), 149
Cytochrome C, 208 for Treponema, 146 δ cells Dermatitis
Cytochrome P-450 Darunavir endocrine pancreas B-complex deficiency, 65
azoles, 199 HIV therapy, 203 somatostatin production, 371 drug reactions and, 250
barbiturates and, 546 Dasabuvir, 204 somatostatinomas of, 351 glucagonomas, 351
cimetidine and, 399 Dasatinib, 443 Delta rhythm (EEG), 497 IPEX syndrome, 102
griseofulvin, 200 Datura, 241 Delta virus, 167 type IV hypersensitivity reaction, 113
interactions with, 252 Daunorubicin, 439 Deltoid muscle vitamin B deficiency, 67
5
macrolides, 193 dilated cardiomyopathy, 248 axillary nerve injury, 447 vitamin B deficiency, 68
7
phenobarbital effect on, 544 DCC gene, 224 Erb palsy, 448 Dermatitis herpetiformis, 481
rifamycins, 196 Deacetylation Delusional disorder, 560 celiac disease and, 381
ritonavir, 203 histones, 34 Delusions, 559 Dermatologic lesion terms, 475
Cytokeratin, 227 Dead space (lung), 664 mesolimbic pathway, 499 Dermatomes
Cytokines, 101, 108 Deafness Demeclocycline landmarks, 510
corticosteroids and, 120 Alport syndrome, 596 diabetes insipidus and, 249, 338 Dermatomyositis, 228
Graves disease and, 342 congenital long QT syndrome, 294 Dementia autoantibody, 115
rejection reactions, 119 congenital syphilis, 147 HIV-positive adults, 177 Dermatomyositis/polymyositis, 471
type IV hypersensitivity, 113 rubella, 182 metachromatic leukodystrophy, 88 Dermatophytes, 152
Cytokinesis, 46 syphilis, 182 neurodegenerative disorders, Dermis, 473
Cytomegalovirus (CMV) Deamination 520–521 Descending colon, 360
AIDS retinitis, 165 base excision repair, 40 prion disease, 178 Desert bumps, 151
cholecystitis and, 396 Death vitamin B deficiency, 67 Desert rheumatism
3
clinical significance, 165 aortic dissection in, 303 Demyelinating/dysmyelinating Coccidioidomycosis, 151
esophagitis and, 377 children, explaining to, 269 disorders, 523 Desflurane, 550
HIV-positive adults, 177 common causes, 272 lead poisoning (adult), 425 Desipramine, 575
hyper-IgM syndrome and, 117 sudden cardiac death, 304 metachromatic leukodystrophy, 88 Desloratadine, 686
immunodeficient patients, 118 thyroid storm, 342 progressive multifocal Desmin, 48, 227
pneumonia, 683 Death receptor pathway, 207, 208 leukoencephalopathy, 524 Desmopressin
TORCH infection, 182 Debranching enzyme vitamin B deficiency, 530 central DI, 329
12
treatment, 202 Cori disease, 87 Dendritic cells, 408 DI treatment, 338
viral receptor, 166 glycogen metabolism, 86 IL-10, 108 for hemophilia, 426
Cytoplasm Decay-accelerating factor (DAF), 106 innate immunity, 99 Desmosome, 474
cell cycle phase, 46 Deceleration injury, 303 T- and B-cell activation, 102, 103 Desquamation
cytoskeletal elements, 48 Decerebrate (extensor) posturing, 511 Dengue, 167 staphylococcal toxic shock
glycolysis, 76 Decidua basalis, 617 Denial, 554 syndrome, 135
HMP shunt, 79 Decision-making capacity, 266 Denosumab, 122 Desvenlafaxine, 575
metabolism in, 72 Decorticate (flexor) posturing, 511 for osteoporosis, 462 Detached retina, 537

FAS1_2019_21_Index_749-806.indd 763 11/21/19 12:27 PM